Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Oncopeptides withdraws Pepaxto®[ ]in US, scale down organization and focus on R&D

STOCKHOLM — October 22, 2021 — Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a global biotech company focused on the development of therapies for difficult-to-treat hematological diseases, today announces that the company has decided to withdraw Pepaxto[® ](INN melphalan flufenamide) from the market in the US, following the phase 3 OCEAN study, which showed an overall survival in the ITT population with a HR of 1.104. The decision has been made after interactions and dialogue with the US Food and Drug Administration, FDA. Pepaxto was granted accelerated approval on February 26[th] 2021.

Latest innovations in RayStation, RayCare and RayIntelligence to be presented at ASTRO 2021

RaySearch Laboratories AB (publ) will be showcasing the latest oncology software innovations at ASTRO 2021 , to be held in Chicago, October 24-27. Attendees will be able to book demonstrations of RayStation®* treatment planning system, RayCare®* oncology information system, and RayIntelligence®, the new cloud-based analytics system for oncology, during the congress.The latest versions of RayStation (11A) and RayCare (5A) were released in May 2021. A new feature in the RayStation release is dose planning for Accuray’s CyberKnife® system for

Targovax invites to webcast presentation on Xtrainvestor

Oslo, Norway, 22 October 2021 – Targovax ASA (OSE: TRVX) has the pleasure of inviting investors, analysts and media to a live webcast presentation held by the company’s newly appointed CEO Erik Digman Wiklund on Monday 25 October at 14:00 CEST.Webcast URL: https://inqrate.com/xtravideos/targovax-trvx-presentasjon-25-oktober/ The presentation will be followed by a Q&A session moderated by analyst in DNB Markets Patrik Ling. Webcast viewers are welcome to submit questions in advance or during the presentation to info@xtrainvestor.com. ***

Invitation to presentation of Orexo´s Q3 Interim Report, on November 3 at 1 pm CET

Uppsala, Sweden – October 22, 2021 – As previously communicated Orexo will announce the Q3 2021 Interim Report, on November 3 at 8 am CET. The same day at 1 pm CET analysts, investors and media are invited to attend a presentation where Nikolaj Sørensen, CEO, Dennis Urbaniak, EVP Digital Therapeutics and Joseph DeFeo, CFO, will present the report. After the presentation a Q&A will be held. Questions can also be sent in advance to ir@orexo.com, no later than 11 am CET. Please view the instructions below on how to participate. Video link: https://tv.streamfabriken.com/orexo-q3-2021

BICO has been awarded the Swedish Government’s Award Exporter of the Year 2021

BICO has today been awarded the Swedish Government’s Award, Exporter of the Year 2021. The Award was presented by the Minister for Foreign Trade Anna Hallberg at a ceremony at the Ministry for Foreign Affairs in Stockholm with the attendance of HRH Prince Daniel. The novel Award is initiated by the Swedish government in effort to promote Swedish exports, by honoring companies that have made particularly meritorious efforts in inspiration and development. The motivation from the Government reads as follows: "BICO Group is a Swedish success story whose products are designed for the

poLight ASA - Invitation to presentation of Q3 2021 results

poLight ASA will release its Q3 2021 results on Friday 29 October 2021 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 08:30 am CEST through live webcast. Please join the Q3 2021 results webcast by clicking here:https://channel.royalcast.com/landingpage/hegnarmedia/20211029_3/ 

TR-1: Standard form for notification of major holdings

TR-1: Standard form for notification of major holdings [][][][][][][]NOTIFICATION OFMAJOR HOLDINGS(to besent to the relevantissuer and tothe FCA in MicrosoftWord format ifpossible)[i] 1a. Identity of the IOG PLCissuer or theunderlying issuer ofexisting sharesto which votingrights areattached[ii]:1b. Please indicateif the issuer isa non-UK issuer (please mark withan "X" ifappropriate)Non-UK issuer2. Reason for thenotification (pleasemark theappropriate box orboxes with an"X")An acquisition or

Registers of true owners of anonymous companies on track to become a requirement worldwide

The Financial Action Task Force’s proposed measures for strengthening the global standard a positive development in eliminating corporate secrecy Transparency International welcomes the proposed amendments  to the global standard on company ownership, released yesterday. The draft revisions, put forward by the Financial Action Task Force (FATF) following a three-day plenary, have the potential to significantly strengthen countries’ resistance to dirty money. Most notably, FATF is finally

Minesto recruits Communications Manager to further strengthen its marketing organisation

Minesto has appointed Cecilia Sernhage as Communications Manager and thus continues to strengthen the company's market organisation ahead of the commercial scale-up of Minesto's unique marine energy technology. Cecilia Sernhage has extensive experience in B2B communication with customers in global markets and provides Minesto with additional expertise and capacity to enhance and create new relationships with various stakeholders and partners.“We are very pleased to strengthen our commercial resources with Cecilia. Having worked for a long time with customer-focused B2B communication in a

HEXPOL Interim Report January - September 2021

JULY - SEPTEMBER 2021 · Sales increased by 23 percent and amounted to 4,108 MSEK (3,328). · EBIT increased by 86 percent to 1,105 MSEK (593). · EBIT-margin increased to 26.9 percent (17.8). · Adjusted EBIT (excl. non-recurring items) increased by 14 percent to 677 MSEK (593). · Adjusted EBIT-margin (excl. non-recurring items) amounted to 16.5 percent (17.8). · Profit after tax increased to 841 MSEK (426). · Earnings per share increased by 97 percent to 2.44 SEK (1.24). · Operating cash flow amounted to 412 MSEK (773). · Non-recurring items, before tax, amounted

Aker Carbon Capture and Elkem to test the world's first carbon capture pilot for smelters

Aker Carbon Capture and Elkem will test the world's first carbon capture plants for emissions from smelters in the process industry, and the first in the production of ferrosilicon. This week, the project received support from the CLIMIT-Demo program run by the Research Council of Norway and Gassnova, and will start up with Elkem Rana and SMA Mineral in Mo Industrial Park.Aker Carbon Capture will use its mobile test unit service, a unique offering with a fully functioning mobile carbon capture plant. The project is a collaboration between Mo Industripark AS, SINTEF, Elkem, Alcoa, Celsa,

Nordic Iron Ore AB extends the short-term loan facility

In February 2021, Nordic Iron Ore AB received a loan facility of SEK 10.5 million from the Company's principal owners Bengtssons Tidnings AB and Ludvika Holding AB and the company's board member Timo Lindborg via companies. The facility has now been extended by six months to run until the end of the first half of 2022. Summary of terms of the loan facility:  • Loan agreement totaling SEK 10.5 million  • The loans have an annual interest rate of 8 percent on the amount used.  • The loans run until 30 June 2022. Overall, the Board has made the assessment that the terms of the

TIE Kinetix Rebrands to Support Growing SaaS Business

TIE Kinetix , a leader in 100% supply chain digitalization, announced today that they have officially rebranded in order to support the continued growth of their cloud-based supply chain platform, FLOW Partner Automation. As a visual representation of the company’s narrowed focus, TIE Kinetix has introduced a new logo and website to better showcase their position as a leader in procure-to-pay and order-to-cash automation.Following the sale of the company’s demand generation business last year, TIE Kinetix immediately scaled down the product offering on

RNB Retail and Brands AB and Coala-Life AB enter into lock-up agreements with shareholders whose ownership amounts to 51 percent of the total number of shares

Due to RNB Retail and Brands AB's (“RNB” or “the Company”) acquisition of Coala-Life AB (“Coala Life”) through a non-cash issue, which was communicated by the Company on September 27, 2021, certain shareholders in Coala Life and in RNB has entered into so-called lock-up agreements with customary terms. According to the agreement, owners who will hold approximately 51 percent of the total number of shares in the Company after completion of the acquisition and the proposed debt conversions that the Company communicated on 15 October 2021, undertake not to sell or otherwise transfer shares in

Initiator Pharma A/S has been approved for listing on the Nasdaq First North Growth Market

Initiator Pharma A/S (“Initiator” or “the Company”) has today received approval for admission to trading on the Nasdaq First North Growth Market. The first day of trading on Nasdaq First North Growth Market is October 25, 2021.Nasdaq Stockholm today announced that Initiator Pharma meets the listing requirements on Nasdaq First North Growth Market and the Company has received approval for admission to trading on Nasdaq First North Growth Market. The first day of trading on Nasdaq First North Growth Market is October 25, 2021. Initiator Pharma's share is currently listed on Spotlight Stock

Klaria Pharma announces approval by the United Stated Patent and Trademark Office of a new patent application covering Naloxone Alginate Film.

With this approval of a new patent, Naloxone Alginate Film will enjoy patent-protected market exclusivity in the United States until 2038.  The approval marks the second time the United States Patent Office (USPTO) has approved a compound/Alginate Film combination patent that protects an individual compound formulated in Klaria’s proprietary Alginate Film.  Thus, the approval of the Naloxone Alginate Film combination patent validates Klaria’s patent strategy in the United States, the world’s most valuable market for pharmaceuticals.Jesper Wiklund, CEO of Klaria said “This approval gives us

Geely Sweden has requested to convert all of its A shares in Volvo Cars into B shares upon Volvo Cars’ IPO

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.Link to Full press release (disclaimer)  THE ABOVE ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT INTENDED TO CONSTITUTE, AND SHOULD NOT BE CONSTRUED AS, AN OFFER TO SELL OR A SOLICITATION OF ANY OFFER TO BUY ANY SECURITIES OF VOLVO CARS, AND SUCH SECURITIES (THE "SECURITIES") IN THE UNITED STATES, AUSTRALIA, CANADA

Norse Atlantic Airways Selects Boeing for Digital Maintenance Solutions

·Norse Atlantic Airways is launch customer for Boeing Mobile Logbook ·New airline also signs multiyear agreement for Maintenance Performance Toolbox and Software Distribution Manager AMSTERDAM, October 20, 2021 - Boeing [NYSE: BA] and Norse Atlantic Airways (Norse) announced today a digital solutions agreement making the airline the launch customer for one of Boeing’s newest digital offerings - Boeing Mobile Logbook. The agreement will enable Norse to improve schedule reliability, increase efficiency and optimize performance. “Innovation and digitalization are key to Norse’s

Midsona's largest shareholder Stena Adactum AB has acquired additional shares

Stena Adactum AB, the largest shareholder of the company, has today acquired 2.75 million class B shares in the company. Stena Adactum AB's holding after the acquisition amounts to 543,928 class A shares and 20,541,011 class B shares.-It shows great confidence in the company when the largest shareholder chooses to increase its ownership in the company. We are very pleased that Stena Adactum continues to invest in the company, says Peter Åsberg, President and CEO of Midsona AB. For more information, please contact President and CEO Peter Åsberg, +46 (0)730 26 16 32 or CFO Max Bokander,

Climate Impact of Heating: Tuzla stands for Transition

Europe’s heating sector continues to be entirely dominated by fossil fuels. According to the latest Global Renewables’ Status Report1, few countries and cities are making progress in planning and supporting progressive, locally adapted solutions that work for citizens, for the economy, and for the environment. Well, not entirely: An indomitable city in Bosnia and Herzegovina aspires to become the role model for the heat transition in the Balkans. Tuzla.When people hear the name Salt Lake City, most think of the capital of the U.S. state of Utah and its world-famous lake. In the Balkans,

Artificial Solutions: Invitation to presentation of Q3 report 2021

Artificial Solutions® (SSME:ASAI), the leading specialist in enterprise-strength conversational AI, will release the interim report for the third quarter of 2021 on Thursday 28th October at 07:30am (CET)The full report and a brief presentation will be available on:https://www.investors.artificial-solutions.com/financial-reports.Conference Call – DetailsPer Ottosson, CEO and Fredrik Törgren, CFO will present the financial results at a telephone conference at 10:00 CET on the same day. To participate in the conference call, please use the dial-in details below. Callers are encouraged to

Arctic Bioscience AS – Notice of extraordinary general meeting: Marita Holstad proposed as new board member

The Board of Directors of Arctic Bioscience AS ("the "Company") has proposed Marita Holstad as new board member and the Board of Directors of the Company calls for an extraordinary general meeting (EGM) for the election.Marita Holstad has extensive experience from the pharmaceutical industry, and is currently Global Vice President, Commercialization Leader respiratory in GlaxoSmithKline (GSK), based in Chicago, IL. Before joining GSK, Marita Holstad has 16 years’ experience from AbbVie (previously Abbott) from management positions in Norway, UK and the US within Immunology across

6 reasons why your brand should communicate with emojis 💬

To bring back a slightly cliché, yet accurate saying:  ✨ A picture says more than a thousand words ✨  While emojis aren’t exactly pictures, they’re the closest you can get in text-format. Emojis are a great visual tool that can portray a wide array of emotions and help spice up your content. Here are six great reasons why you should leverage the power of emojis in your brand communication: 1. They help your text stand out 💥People have short attention spans, and they just keep getting shorter. We get bored easily, our brains are constantly looking for something to

Financial Report July – September 2021

Stockholm, Sweden, October 22, 2021(NYSE: ALV and SSE: ALIV.sdb)Q3 2021: Accelerating global supply chain disruptions Financial highlights Q3 2021 $1,847m net sales12% organic sales decline*5.4% operating margin5.6% adjusted operating margin*$0.68 EPS - a decrease of $0.44$0.73 adjusted EPS* - a decrease of $0.75 Full year 2021 indications Around 11% net sales growthAround 8% organic sales growthAround 8% adjusted operating margin  Key business developments in the third quarter of 2021 · Significant organic sales decline* as global LVP declined by 20%

There are no items matching the current filter
There are no more items matching the current filter
Back to top